Krebs Biochemicals & Industries Limited (BOM:524518)
75.85
+2.85 (3.90%)
At close: May 7, 2025
BOM:524518 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Cash & Equivalents | - | 1.37 | 0.86 | 1.01 | 7.11 | 1.74 | Upgrade
|
Cash & Short-Term Investments | 1.44 | 1.37 | 0.86 | 1.01 | 7.11 | 1.74 | Upgrade
|
Cash Growth | 84.16% | 60.14% | -14.71% | -85.84% | 307.75% | -98.99% | Upgrade
|
Accounts Receivable | - | 47.27 | 6.51 | 8.77 | 3 | 2.02 | Upgrade
|
Other Receivables | - | 1.67 | 1.36 | 0.97 | 0.77 | 0.72 | Upgrade
|
Receivables | - | 48.95 | 7.87 | 9.73 | 3.76 | 2.74 | Upgrade
|
Inventory | - | 102.45 | 123.56 | 258.65 | 168.91 | 153.89 | Upgrade
|
Prepaid Expenses | - | 3.76 | 5.18 | 4.93 | 3.95 | 2.4 | Upgrade
|
Other Current Assets | - | 17.9 | 23.14 | 80.62 | 30.45 | 27.84 | Upgrade
|
Total Current Assets | - | 174.42 | 160.61 | 354.93 | 214.18 | 188.6 | Upgrade
|
Property, Plant & Equipment | - | 1,495 | 1,487 | 1,442 | 1,264 | 1,057 | Upgrade
|
Other Intangible Assets | - | 18.47 | 18.47 | 18.47 | 18.47 | 18.47 | Upgrade
|
Long-Term Deferred Charges | - | 6.56 | 8.4 | 10.24 | 16.62 | 19.23 | Upgrade
|
Other Long-Term Assets | - | 87.73 | 75.22 | 72.26 | 79.39 | 54.59 | Upgrade
|
Total Assets | - | 1,782 | 1,750 | 1,898 | 1,592 | 1,338 | Upgrade
|
Accounts Payable | - | 189.7 | 152.81 | 395.47 | 172.46 | 200.3 | Upgrade
|
Accrued Expenses | - | 128.61 | 95.29 | 119.75 | 111.97 | 137.15 | Upgrade
|
Short-Term Debt | - | 99.3 | 99.9 | 99.86 | 100 | - | Upgrade
|
Current Portion of Long-Term Debt | - | 2.47 | 1.34 | 1.83 | 5.92 | 7.07 | Upgrade
|
Other Current Liabilities | - | 198.27 | 141.71 | 163.73 | 91.58 | 86.82 | Upgrade
|
Total Current Liabilities | - | 618.34 | 491.05 | 780.64 | 481.92 | 431.34 | Upgrade
|
Long-Term Debt | - | 1,835 | 1,732 | 1,329 | 1,005 | 655.06 | Upgrade
|
Other Long-Term Liabilities | - | 495.01 | 498.03 | 515.73 | 511.52 | 481.61 | Upgrade
|
Total Liabilities | - | 2,974 | 2,744 | 2,649 | 2,020 | 1,588 | Upgrade
|
Common Stock | - | 215.61 | 215.61 | 215.61 | 196.21 | 180.01 | Upgrade
|
Additional Paid-In Capital | - | 1,180 | 1,180 | 1,180 | 1,033 | 909.62 | Upgrade
|
Retained Earnings | - | -2,702 | -2,505 | -2,261 | -1,812 | -1,531 | Upgrade
|
Comprehensive Income & Other | - | 114.45 | 114.45 | 114.45 | 156.16 | 190.99 | Upgrade
|
Shareholders' Equity | -1,301 | -1,192 | -994.62 | -750.93 | -427.33 | -249.96 | Upgrade
|
Total Liabilities & Equity | - | 1,782 | 1,750 | 1,898 | 1,592 | 1,338 | Upgrade
|
Total Debt | 2,046 | 1,937 | 1,834 | 1,431 | 1,111 | 662.13 | Upgrade
|
Net Cash (Debt) | -2,044 | -1,935 | -1,833 | -1,430 | -1,104 | -660.38 | Upgrade
|
Net Cash Per Share | -94.80 | -89.77 | -85.01 | -66.32 | -56.28 | -36.69 | Upgrade
|
Filing Date Shares Outstanding | 21.56 | 21.56 | 21.56 | 21.56 | 21.56 | 18 | Upgrade
|
Total Common Shares Outstanding | 21.56 | 21.56 | 21.56 | 21.56 | 19.62 | 18 | Upgrade
|
Working Capital | - | -443.92 | -330.44 | -425.71 | -267.75 | -242.74 | Upgrade
|
Book Value Per Share | -60.32 | -55.29 | -46.13 | -34.83 | -21.78 | -13.89 | Upgrade
|
Tangible Book Value | -1,320 | -1,211 | -1,013 | -769.4 | -445.8 | -268.43 | Upgrade
|
Tangible Book Value Per Share | -61.18 | -56.15 | -46.99 | -35.69 | -22.72 | -14.91 | Upgrade
|
Land | - | 484.19 | 484.19 | 484.19 | 484.19 | 484.19 | Upgrade
|
Buildings | - | 273.02 | 266.37 | 256.92 | 221.79 | 204.65 | Upgrade
|
Machinery | - | 2,335 | 2,248 | 2,106 | 1,871 | 1,711 | Upgrade
|
Construction In Progress | - | 1.56 | 22.43 | 65.31 | 100.89 | 23.46 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.